Article

barrons.com on 2022-01-10 14:35

Year's Biggest Healthcare Conference Starts With Lots of Deals, No Blockbuster M&A2 min read

The lack of major biotech acquisitions could be a disappointment to investors, who had been hoping for a busy 2022 for mergers.

Related news